MedTrace Logo

A Feasibility Trial of OCM Supplements for the Treatment of NAFLD

NCT05720702 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 31

Last updated 2024-11-27

No results posted yet for this study

Summary

The purpose of the study is to assess the feasibility of a trial to test the effects of homocysteine (Hcy) lowering supplements in patients with NAFLD.

NAFLD patients will be asked to take Hcy lowering supplements (Vitamin B12, Folate, Vitamin B6, and Betaine) daily for 12 weeks. Over the course of approximately 12 to 13 weeks, participants will complete two in person visits and two phone visits to complete activities such as physical exam, fibroscan, blood draws, and questionnaires.

Conditions

  • NAFLD

Interventions

DIETARY_SUPPLEMENT

homocysteine (Hcy) lowering supplements

NAFLD participants will take homocysteine (Hcy) lowering supplements daily for 12 weeks.

Sponsors & Collaborators

Principal Investigators

  • Ayako Suzuki · Duke University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-30
Primary Completion
2024-08-23
Completion
2024-08-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05720702 on ClinicalTrials.gov